Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10275579rdf:typepubmed:Citationlld:pubmed
pubmed-article:10275579lifeskim:mentionsumls-concept:C0206222lld:lifeskim
pubmed-article:10275579lifeskim:mentionsumls-concept:C0085550lld:lifeskim
pubmed-article:10275579lifeskim:mentionsumls-concept:C1553526lld:lifeskim
pubmed-article:10275579lifeskim:mentionsumls-concept:C2916913lld:lifeskim
pubmed-article:10275579lifeskim:mentionsumls-concept:C1708476lld:lifeskim
pubmed-article:10275579pubmed:issue3lld:pubmed
pubmed-article:10275579pubmed:dateCreated1986-4-11lld:pubmed
pubmed-article:10275579pubmed:abstractTextThe effects of implementing a closed formulary system and group purchasing in a 343-bed, private, nonprofit community hospital were evaluated by use of price and value indexes. Four therapeutic categories were analyzed: antihistamines and decongestants, antitussives, antacids, and topical corticosteroidal creams and ointments. Overall savings in the four therapeutic categories evaluated totaled $681.33. The findings indicated differences in cost may exist between formulary and nonformulary drugs, but the direction and magnitude of that difference vary with the therapeutic category. The impact of group purchasing affiliation on overall purchase cost is discussed and additional cost-control methods are presented.lld:pubmed
pubmed-article:10275579pubmed:languageenglld:pubmed
pubmed-article:10275579pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10275579pubmed:citationSubsetHlld:pubmed
pubmed-article:10275579pubmed:statusMEDLINElld:pubmed
pubmed-article:10275579pubmed:monthMarlld:pubmed
pubmed-article:10275579pubmed:issn0098-6909lld:pubmed
pubmed-article:10275579pubmed:authorpubmed-author:SylvesterK...lld:pubmed
pubmed-article:10275579pubmed:authorpubmed-author:WuddsT WTWlld:pubmed
pubmed-article:10275579pubmed:issnTypePrintlld:pubmed
pubmed-article:10275579pubmed:volume21lld:pubmed
pubmed-article:10275579pubmed:ownerNLMlld:pubmed
pubmed-article:10275579pubmed:authorsCompleteYlld:pubmed
pubmed-article:10275579pubmed:pagination357-60, 369-70lld:pubmed
pubmed-article:10275579pubmed:dateRevised2000-12-18lld:pubmed
pubmed-article:10275579pubmed:meshHeadingpubmed-meshheading:10275579...lld:pubmed
pubmed-article:10275579pubmed:meshHeadingpubmed-meshheading:10275579...lld:pubmed
pubmed-article:10275579pubmed:meshHeadingpubmed-meshheading:10275579...lld:pubmed
pubmed-article:10275579pubmed:meshHeadingpubmed-meshheading:10275579...lld:pubmed
pubmed-article:10275579pubmed:meshHeadingpubmed-meshheading:10275579...lld:pubmed
pubmed-article:10275579pubmed:year1986lld:pubmed
pubmed-article:10275579pubmed:articleTitleCost savings through formulary implementation and group purchasing in four therapeutic categories.lld:pubmed
pubmed-article:10275579pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10275579lld:pubmed